Phillip G Febbo

4PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.

Meng Zhang, Martin Sjöström, Xiekui Cui

|Jan 02, 2024
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care.

Phillip G Febbo, Mina Allo, Emma B Alme

|Aug 30, 2022
Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy.

Victoria N Parikh, Alexander G Ioannidis, David Jimenez-Morales

|Dec 30, 2021
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).

Andrew B Nixon, Susan Halabi, Yingmiao Liu

Pageof 1

Frequent Collaborators

1 joint publications

Victoria N Parikh

1 joint publications

Alexander G Ioannidis

1 joint publications

David Jimenez-Morales

1 joint publications

Hannah N De Jong